Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Westburg BV

Molecular Detection Inc.

Methicillin-resistant staphylococcus aureus infections are deadly for patients and expensive for hospitals to treat. Current methods of detecting MRSA are plagued with significant numbers of false-positive results. Molecular Detection Inc.’s Detect-Ready screening assay is designed to distinguish accurately if a positive result indicates the presence of MRSA or a combination of different bacteria, some of which may not be resistant to antibiotics. The test can be run with equipment found in most clinical laboratories, enabling hospitals to make informed clinical decisions about the best way to treat patients.

Medical Device

Deals Shaping the Medical Industry (12/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Medical Device
See All

Company Information

  • Industry
  • Distributors